Therapeutic potential of human umbilical cord–derived mesenchymal stem cells transplantation in rats with optic nerve injury

Purpose: There are no effective treatments currently available for optic nerve transection injuries. Stem cell therapy represents a feasible future treatment option. This study investigated the therapeutic potential of human umbilical cord–derived mesenchymal stem cell (hUC?MSC) transplantation in rats with optic nerve injury. Methods: Sprague–Dawley (SD) rats were divided into three groups: a no?treatment control group (n = 6), balanced salt solution (BSS) treatment group (n = 6), and hUC?MSCs treatment group (n = 6). Visual functions were assessed by flash visual evoked potential (fVEP) at baseline, Week 3, and Week 6 after optic nerve crush injury. Right eyes were enucleated after 6 weeks for histology. Results: The fVEP showed shortened latency delay and increased amplitude in the hUC?MSCs treated group compared with control and BSS groups. Higher cellular density was detected in the hUC?MSC treated group compared with the BSS and control groups. Co?localized expression of STEM 121 and anti?S100B antibody was observed in areas of higher nuclear density, both in the central and peripheral regions. Conclusion: Peribulbar transplantation of hUC?MSCs demonstrated cellular integration that can potentially preserve the optic nerve function with a significant shorter latency delay in fVEP and higher nuclear density on histology, and immunohistochemical studies observed cell migration particularly to the peripheral regions of the optic nerve.

Effect of microencapsulated blends of organic acids and essential oils supplementation on growth performance and nutrient digestibility in finishing pigs / Efecto de mezclas microencapsuladas de ácidos orgánicos y suplementos de aceites esenciales sobre el crecimiento y digestibilidad de nutrientes de cerdos en ceba / Efeito de misturas de ácidos orgânicos microencapsulados e suplementação de óleos essenciais sobre o crescimento e a digestibilidade dos nutrientes em suínos em terminação

Background: positive effects of organic acids and essential oils (MOE) on livestock are well documented. Microencapsulation allows the slow release of core materials in a specific moment or environment. Objective: to evaluate the effect of supplementing finishing pigs with microencapsulated blends of organic acids and essential oils (MOE) on growth performance, nutrient digestibility, fecal noxious gas emissions, and meat quality. Methods: 75 crossbred pigs [(Yorkshire × Landrace) × Duroc, 56.15 ± 3.77 kg] were used in this 10-week trial. Pigs were randomly distributed into 1 of 3 dietary treatments on the basis of body weight (BW) and gender. Each treatment had 5 replicate pens with 5 pigs (2 gilts, 3 barrows) per pen. Treatments were as follows: CON (a basal diet); MOE1 (CON + 0.025% MOE); MOE2 (CON + 0.050% MOE). Results: pigs fed the MOE2 diet had higher final BW at 5th and 10th week than those fed the CON diet (p<0.05). During weeks 0 to 5, MOE1 and MOE2 groups had greater average daily gain (ADG) than the CON group (p<0.05). Overall, ADG in MOE2 was greater than that in CON treatment (p<0.05). MOE2 group had higher dry matter (DM) and energy digestibility than the CON group (p<0.05). Conclusion: the present results indicate that dietary supplementation with 0.05% MOE improves growth performance and nutrient digestibility in finishing pigs.

Antecedentes: los efectos positivos de los ácidos orgánicos y aceites esenciales (MOE) en el ganado han sido documentados. La microencapsulación permite la liberación lenta del material de núcleo en un período o medio ambiente particulares. Objetivo: evaluar el efecto de suplementar cerdos de engorde con mezclas microencapsuladas de ácidos orgánicos y aceites esenciales (MOE) sobre el rendimiento productivo, la digestibilidad de nutrientes, las emisiones de gases fecales, y la calidad de la carne. Métodos: 75 cerdos cruzados [(Yorkshire × Landrace) x Duroc), 56,15 ± 3,77 kg] se utilizaron en las 10 semanas que duró el ensayo. Los cerdos se distribuyeron aleatoriamente en 1 de 3 tratamientos dietarios, de acuerdo con su peso corporal (BW) y género. Cada tratamiento tuvo 5 réplicas (corrales) con 5 cerdos por corral (2 hembras y 3 machos castrados). Los tratamientos fueron: CON (dieta basal); MOE1 (CON + 0,025% MOE); MOE2 (CON + 0,050% MOE). Resultados: los cerdos alimentados con la dieta MOE2 tuvieron mayor BW final en las semanas 5ª y 10ª que los alimentados con la dieta CON (p<0,05). Durante la semana 0 a la 5 los grupos MOE1 y MOE2 tuvieron mayor ganancia media diaria (ADG) que el grupo CON (p<0,05). En general, la ADG de MOE2 fue mayor que en el tratamiento CON (p<0,05). El grupo MOE2 tuvo mayor digestibilidad de la materia seca (DM) y de la energía que el grupo CON (p<0,05). Conclusión: los resultados indican que la suplementación de la dieta con 0,05% MOE mejora el crecimiento y la digestibilidad de nutrientes en cerdos de ceba.

Antecedentes: os efeitos positivos de ácidos orgânicos e óleos essenciais (MOE) para o gado estão bem documentados na literatura. A microencapsulação permite a liberação lenta de materiais centrais num momento ou ambiente específico. Objetivos: avaliar os efeitos de suplementação de suínos em terminação com misturas microencapsuladas de ácidos orgânicos e óleos essenciais (MOE) em pontos como desempenho produtivo, digestibilidade dos nutrientes, emissões de gases nocivos fecais e qualidade da carne. Metodologia: 75 suínos mestiços [(Yorkshire × Landrace) x Duroc), 56,15 ± 3,77 kg] foram utilizados neste teste de 10 semanas. Os animais foram selecionados aleatoriamente em 1 de 3 currais de tratamento dietético, com base no peso corporal (BW) e sexo. Cada curral teve 5 réplicas e cada curral, 5 suínos (2 fêmeas, 3 machos castrados). Os tratamentos foram os seguintes: CON (dieta basal); MOE1 (CON + 0,025% MOE); MOE2 (CON + 0,050% MOE). Resultados: os animais que receberam a dieta MOE2 apresentaram significativamente maior PV final em 5 e 10 semanas do que aqueles alimentados com a dieta CON (p<0,05). Durante 0-5 semanas, os grupos MOE1 e MOE2 tiveram maior GMD que o grupo CON (p<0,05). De um modo geral, ADG de MOE2 foi maior do que no grupo CON (p<0,05). O grupo MOE2 teve a matéria seca (DM) e a digestibilidade de energia maiores do que o grupo CON (p<0,05). Conclusão: os resultados indicam que a suplementação dietética com 0.05% de MOE melhora o desempenho do crescimento e digestibilidade de nutrientes em suínos em terminação.

Standardization of anti-lethal toxin potency test of antivenoms prepared from two different Agkistrodon halys venoms

In Korea, antivenoms for the treatment of patients bitten by venomous snakes have been imported from Japan or China. Although there is cross-reactivity between these antibodies and venoms from snakes indigenous to Korea (e.g. Agkistrodon genus), protection is not optimal. Antivenoms specifically prepared to neutralize Korean snake venoms could be more effective, with fewer side effects. To this end, we established an infrastructure to develop national standards and created a standardized method to evaluate the efficacy of two horse-derived antivenoms using mouse lethal toxin test. Additionally, we determined the antivenoms neutralizing activity against lethal doses (LD50) of Agkistrodon halys (from Japan) and Jiangzhe Agkistrodon halys (from China) venoms. We also performed cross-neutralization tests using probit analysis on each pairing of venom and antivenom in order to check the possibility of using Jiangzhe A. halys venom as a substitute for A. halys venom, the current standard. Slope of A. halys venom with A. halys antivenom was 10.2 and that of A. halys venom with Jiangzhe A. halys antivenom was 9.6. However, Slope of Jiangzhe A. halys venom with A. halys antivenom was 4.7 while that of Jiangzhe A. halys venom with Jiangzhe A. halys antivenom was 11.5. Therefore, the significant difference in slope patterns suggests that Jiangzhe A. halys venom cannot be used as a substitute for the standard venom to test the anti-lethal toxin activity of antivenoms (p<0.05).(AU)

Standardization of an antihemorrhagic potency test of antivenoms prepared from two different Agkistrodon halys venoms

To establish Korea National Standards for venoms and antivenoms, it is necessary to have standardized assay methods. In this study, we standardized a method to evaluate the antihemorrhagic potency of two horse-derived antivenoms using rabbit intracutaneous injection. We expressed the capability of these antivenoms to neutralize the hemorrhagic activities triggered by the venoms of Agkistrodon halys from Japan and Jiangzhe Agkistrodon halys from China as Minimum Hemorrhagic Dose (MHD). We also performed cross-neutralization tests employing the parallel line assay on different pairings of venoms and antivenoms to check the possibility of using Jiangzhe Agkistrodon halys venom as a substitute for the standard Agkistrodon halys venom in measurements of the antihemorrhagic activity, since A. halys venom is not easily available. Slope function ratio (S.R.) was 0.957 for Agkistrodon halys venom either with Agkistrodon halys antivenom or with Jiangzhe Agkistrodon halys antivenom (p>0.05). Similarly, S.R. was 0.348 for Jiangzhe Agkistrodon halys venom either with Agkistrodon halys antivenom or with Jiangzhe Agkistrodon halys antivenom (p>0.05). Thus, in this study we established antihemorrhagic potency test methods for both Agkistrodon halys and Jiangzhe Agkistrodon halys antivenoms and we could also show it is possible to use Jiangzhe Agkistrodon halys venom as a standard.

Promotion of insecticide-treated mosquito nets in Myanmar.

A simple health promotion message administered by village midwives raised bednet usage to over 60% in trial hamlets in north Shan State, Myanmar. Treatment of the nets in the study villages produced a reduction in malaria cases. Most villagers were prepared to buy their nets at market prices and were willing to pay for the cost of re-treatment of nets, but very poor, members of the Wa ethnic group required a half-price subsidy for them to afford them. The use of insecticide treated bednets was felt to be appropriate for undeveloped and remote areas of the country where malaria control was difficult.

Serum cortisol levels in patients with uncomplicated and cerebral malaria.

Ten patients with uncomplicated malaria, ten with cerebral malaria and 37 controls (blood donors from blood bank) were included in the study. The serum cortisol levels of the patients were determined daily for 7 days while they were at the hospital. A radio-immunoassay method was used for quantitative measurement of cortisol in human serum. The mean serum cortisol level of patients with uncomplicated malaria was 528.2 +/- 123.9 nmol/l, with cerebral malaria was 516.0 +/- 80.5 nmol/l, and in controls was 393.8 +/- 141.0 nmol/l. There was a significant rise of serum cortisol levels in patients with malaria when compared to controls at the day of admission to hospital. There was no significant difference between uncomplicated malaria patients and those with cerebral malaria. There was also no significant difference between the different days of treatment up till day 7. We found no cortisol insufficiency in cases with falciparum malaria during acute and convalescent stages of illness.